Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Ecol. Evol.

Sec. Conservation and Restoration Ecology

This article is part of the Research TopicThe North American Bison Management System: Sustainability, One Health, Ecological Restoration, and Ecological ResilienceView all 14 articles

Bluetongue and Epizootic Hemorrhagic Disease in Bison bison and Bison bonasus: Current Knowledge and Future Directions

Provisionally accepted
  • Colorado State University, Fort Collins, United States

The final, formatted version of the article will be published soon.

Orbiviruses such as Bluetongue virus (BTV) and Epizootic Hemorrhagic Disease virus (EHDV) represent a growing vector-borne threat at the wildlife-livestock interface and are directly relevant to One Health, bison management, and ecological resilience. These pathogens, transmitted by Culicoides midges, are increasingly influenced by climate and land-use change, leading to shifts in their geographic range, intensity of circulation, and strain diversity. As an ecologically, economically, and culturally significant species that spans the boundary between wildlife and livestock classifications, North American bison are uniquely positioned within this disease landscape. Yet, bison remain underrepresented in orbivirus surveillance and research. A literature review synthesizing what is known and what is still unknown about orbivirus epidemiology, host competence, serotype diversity, and immunological responses in bison would give a much-needed foundation in understanding bison health and its implications for broader ruminant disease dynamics. This work aligns directly with the goals of the special edition by advancing sustainable bison health management, supporting tribal and conservation herd resilience, and informing integrated vector-borne disease mitigation within a changing climate through a One Health lens.

Keywords: Bison, Bluetongue, EHDV, epizootic hemorragic disease, European bison, North American bison, Orbivirus

Received: 20 Aug 2025; Accepted: 21 Jan 2026.

Copyright: © 2026 Krus, Sherman and Mayo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Christie E. Mayo

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.